We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGOW
1576
CALL
DELISTED
Legato Merger Corp. Warrant
LEGOW
$1.54M 0.01%
+153,304
New +$147K
WING icon
1577
Wingstop
WING
$3.67B
$1.53M 0.01%
9,731
+6,732
+224% +$970K
PFE icon
1578
Pfizer
PFE
$144B
$1.53M 0.01%
39,114
-791,097
-95% -$30.8M
SID icon
1579
Companhia Siderúrgica Nacional
SID
$1.46B
$1.53M 0.01%
+174,150
New +$1.51M
SVFA
1580
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$1.53M 0.01%
154,715
-4,955
-3% -$49.8K
PRPC
1581
DELISTED
CC Neuberger Principal Holdings III
PRPC
$1.53M 0.01%
+156,215
New +$1.54M
EIDO icon
1582
iShares MSCI Indonesia ETF
EIDO
$467M
$1.52M 0.01%
+75,119
New +$1.62M
NKTR icon
1583
Nektar Therapeutics
NKTR
$2.39B
$1.52M 0.01%
+5,917
New +$1.64M
VTIQ
1584
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$1.52M 0.01%
151,928
+103,158
+212% +$1.02M
SRPT icon
1585
Sarepta Therapeutics
SRPT
$1.63B
$1.52M 0.01%
19,519
-3,617
-16% -$274K
BXMT icon
1586
Blackstone Mortgage Trust
BXMT
$2.81B
$1.52M 0.01%
+47,536
New +$1.53M
BP icon
1587
BP
BP
$107B
$1.51M 0.01%
+57,345
New +$1.5M
SRAX
1588
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$1.51M 0.01%
278,455
+122,140
+78% +$587K
PLAY icon
1589
Dave & Buster's
PLAY
$361M
$1.51M 0.01%
37,260
+16,294
+78% +$705K
SCS
1590
DELISTED
Steelcase
SCS
$1.51M 0.01%
99,782
+54,588
+121% +$787K
TIO
1591
DELISTED
Tingo Group, Inc. Common Stock
TIO
$1.5M 0.01%
643,137
+590,309
+1,117% +$1.13M
UPLD icon
1592
Upland Software
UPLD
$14.4M
$1.5M 0.01%
3,653
-8,589
-70% -$3.78M
TINV.WS
1593
CALL
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$1.5M 0.01%
149,996
BKLN icon
1594
Invesco Senior Loan ETF
BKLN
$6.97B
$1.5M 0.01%
67,875
-469,426
-87% -$10.4M
IFF icon
1595
International Flavors & Fragrances
IFF
$20.2B
$1.5M 0.01%
10,056
-199,761
-95% -$28.7M
EFTR
1596
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.5M 0.01%
6,068
+4,069
+204% +$1M
HHLA.WS
1597
CALL
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$1.5M 0.01%
+154,337
New +$115K
BURU.WS
1598
CALL
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$1.5M 0.01%
150,000
+68,515
+84% +$77.1K
VLATU
1599
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
$1.49M 0.01%
+150,000
New +$1.5M
ROK icon
1600
Rockwell Automation
ROK
$52.4B
$1.49M 0.01%
+5,205
New +$1.4M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.